Recently Viewed

Clear All
News Announcement

Lupin: Exclusive License Agreement With Visus Therapeutics Inc. U.S.A.

20-Aug-2026 Follow Value Research Online on Google download pdfDownload PDF Lupin

VISUfarma B.V. the Netherlands a wholly owned subsidiary of the Company has entered into an Exclusive License Agreement with Visus Therapeutics Inc. U.S.A.

Ask Value Research aks value research information

No question is too small. Share your queries on personal finance, mutual funds, or stocks and let us simplify things for you.

These are advertorial stories which keeps Value Research free for all. Click here to mark your interest for an ad-free experience in a paid plan